tiprankstipranks
Trending News
More News >
Biotest AG (GB:0N70)
:0N70
UK Market

Biotest (0N70) Ratios

Compare
0 Followers

Biotest Ratios

GB:0N70's free cash flow for Q4 2024 was €0.26. For the 2024 fiscal year, GB:0N70's free cash flow was decreased by € and operating cash flow was €0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
5.06 1.96 4.76 4.91 5.27
Quick Ratio
2.06 0.88 2.50 2.61 2.52
Cash Ratio
0.67 0.28 0.90 0.98 0.68
Solvency Ratio
0.07 0.18 <0.01 -0.04 >-0.01
Operating Cash Flow Ratio
0.38 >-0.01 -0.31 0.32 -0.16
Short-Term Operating Cash Flow Coverage
304.50 -0.01 -8.44 1.13 -0.78
Net Current Asset Value
€ -93.80M€ -155.50M€ -212.50M€ -201.60M€ -133.40M
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.49 0.48 0.45 0.41
Debt-to-Equity Ratio
1.13 1.38 1.55 1.30 1.06
Debt-to-Capital Ratio
0.53 0.58 0.61 0.57 0.52
Long-Term Debt-to-Capital Ratio
0.50 0.43 0.61 0.55 0.50
Financial Leverage Ratio
2.70 2.83 3.24 2.90 2.56
Debt Service Coverage Ratio
2.99 0.68 1.12 -0.43 0.41
Interest Coverage Ratio
2.84 3.59 -0.66 -3.95 -0.93
Debt to Market Cap
0.54 0.51 0.44 0.33 0.41
Interest Debt Per Share
16.95 18.44 15.01 12.88 12.21
Net Debt to EBITDA
4.06 3.25 16.17 -22.14 24.86
Profitability Margins
Gross Profit Margin
30.82%40.94%24.20%15.65%26.87%
EBIT Margin
10.99%21.37%-2.15%-9.58%-3.26%
EBITDA Margin
16.58%26.15%5.48%-3.43%3.30%
Operating Profit Margin
13.01%20.96%-2.52%-10.10%-2.73%
Pretax Profit Margin
6.40%15.53%-5.97%-12.14%-6.20%
Net Profit Margin
3.64%18.55%-6.12%-12.28%-6.48%
Continuous Operations Profit Margin
3.64%18.55%-6.14%-12.30%-6.48%
Net Income Per EBT
56.77%119.47%102.60%101.12%104.67%
EBT Per EBIT
49.21%74.08%236.92%120.15%227.27%
Return on Assets (ROA)
1.84%9.00%-2.63%-5.73%-2.78%
Return on Equity (ROE)
4.97%25.46%-8.52%-16.64%-7.11%
Return on Capital Employed (ROCE)
7.42%13.99%-1.21%-5.22%-1.29%
Return on Invested Capital (ROIC)
4.18%13.00%-1.23%-5.10%-1.31%
Return on Tangible Assets
1.86%9.10%-2.66%-5.79%-2.81%
Earnings Yield
2.63%10.29%-2.35%-4.14%-2.82%
Efficiency Ratios
Receivables Turnover
0.00 3.31 2.87 3.21 2.70
Payables Turnover
5.68 5.18 7.66 11.21 8.43
Inventory Turnover
1.05 0.96 1.33 1.78 1.22
Fixed Asset Turnover
1.27 1.18 0.94 0.94 0.88
Asset Turnover
0.51 0.49 0.43 0.47 0.43
Working Capital Turnover Ratio
1.42 1.59 1.14 1.19 1.13
Cash Conversion Cycle
284.14 418.11 353.68 286.55 390.82
Days of Sales Outstanding
0.00 110.26 127.23 113.83 135.08
Days of Inventory Outstanding
348.36 378.36 274.12 205.29 299.03
Days of Payables Outstanding
64.22 70.51 47.68 32.56 43.29
Operating Cycle
348.36 488.62 401.35 319.12 434.11
Cash Flow Ratios
Operating Cash Flow Per Share
1.64 -0.07 -1.02 0.86 -0.42
Free Cash Flow Per Share
0.87 -0.91 -1.76 0.40 -1.10
CapEx Per Share
0.77 0.84 0.74 0.46 0.68
Free Cash Flow to Operating Cash Flow
0.53 13.37 1.72 0.46 2.62
Dividend Paid and CapEx Coverage Ratio
2.01 -0.08 -1.35 1.78 -0.60
Capital Expenditure Coverage Ratio
2.12 -0.08 -1.38 1.86 -0.62
Operating Cash Flow Coverage Ratio
0.10 >-0.01 -0.07 0.07 -0.04
Operating Cash Flow to Sales Ratio
0.08 >-0.01 -0.08 0.07 -0.03
Free Cash Flow Yield
3.21%-2.92%-5.19%1.03%-3.93%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
38.05 9.72 -42.58 -24.13 -35.41
Price-to-Sales (P/S) Ratio
1.38 1.80 2.61 2.96 2.30
Price-to-Book (P/B) Ratio
1.89 2.47 3.63 4.02 2.52
Price-to-Free Cash Flow (P/FCF) Ratio
31.19 -34.20 -19.28 97.29 -25.45
Price-to-Operating Cash Flow Ratio
16.49 -457.27 -33.22 45.06 -66.58
Price-to-Earnings Growth (PEG) Ratio
-0.49 -0.02 0.85 -0.24 -0.06
Price-to-Fair Value
1.89 2.47 3.63 4.02 2.52
Enterprise Value Multiple
12.41 10.15 63.71 -108.44 94.36
EV to EBITDA
12.41 10.15 63.71 -108.44 94.36
EV to Sales
2.06 2.65 3.49 3.72 3.12
EV to Free Cash Flow
46.39 -50.31 -25.83 122.25 -34.55
EV to Operating Cash Flow
24.53 -672.71 -44.52 56.62 -90.40
Tangible Book Value Per Share
13.82 12.23 8.96 9.33 10.81
Shareholders’ Equity Per Share
14.27 12.61 9.38 9.61 11.16
Tax and Other Ratios
Effective Tax Rate
0.43 -0.19 -0.03 -0.01 -0.05
Revenue Per Share
19.52 17.30 13.04 13.03 12.24
Net Income Per Share
0.71 3.21 -0.80 -1.60 -0.79
Tax Burden
0.57 1.19 1.03 1.01 1.05
Interest Burden
0.58 0.73 2.77 1.27 1.90
Research & Development to Revenue
0.08 0.10 0.10 0.10 0.12
SG&A to Revenue
0.05 0.04 0.06 0.06 0.06
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
2.31 -0.02 -1.28 -0.53 0.56
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis